Search

Your search keyword '"Falzetti, Franca"' showing total 482 results

Search Constraints

Start Over You searched for: Author "Falzetti, Franca" Remove constraint Author: "Falzetti, Franca"
482 results on '"Falzetti, Franca"'

Search Results

1. A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect

2. Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML

3. Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

4. Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

7. Clinical-Grade–Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell–Dependent Graft-versus-Leukemia Effect in Murine Models

10. Figure S10 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

11. Supplementary Figure S1 from Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma

14. Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis

17. T regulatory cell separation for clinical application

19. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

21. Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML

22. Acute GvHD after HLA-Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes

24. Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

25. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity

26. CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice

32. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35

35. Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia

36. Predictive Factors for Overall Survival in Chronic Myeloid Leukemia Patients: An Analysis By the Gimema Cml Italian Study

41. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL

42. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

43. Adoptive Immunotherapy with Regulatory and Conventional T Cells in Haploidentical Transplantation Primes Dendritic Cells to Promote T Cell Alloreactivity in the Bone Marrow and Tolerance in the Periphery

44. Preliminary Results of CML1214, a Survey on Ponatinib Compassionate Use in Italy By the Gimema CML Working Party

45. Activation of Regulatory T Cells with IL-2 and TNF-α to Promote Homing to the Gut and to Improve Acute GvHD Prevention

46. Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation

48. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

49. Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia

50. The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview

Catalog

Books, media, physical & digital resources